建立 RCPA 国家抗生素选择性报告指南：流程、挑战和影响评估。
Establishment of RCPA national guidelines for selective reporting of antimicrobials: processes, challenges and measuring the impact.
机构信息
Department of Microbiology and Infectious Diseases, Monash Health, Clayton, Victoria, Australia.
Faculty of Medicine Nursing & Health Sciences, Monash University, Clayton, Victoria, Australia.
出版信息
J Antimicrob Chemother. 2022 Oct 28;77(11):3064-3068. doi: 10.1093/jac/dkac279.
OBJECTIVES
In 2016, The Royal College of Pathologists of Australasia (RCPA) initiated the formation of a working group comprising medical microbiologists to establish guidelines to assist Australian laboratories to implement selective and cascade reporting of antimicrobials-the first guidelines of this type in the world.
METHODS
A 2017 audit of antimicrobial reporting in Australian and New Zealand laboratories identified significant opportunities for improvement and standardization of selective reporting.
RESULTS
The first draft of the RCPA Selective Reporting Guidelines was circulated to all RCPA Microbiology fellows for feedback in August 2018 and the first version was published in February 2019. Subsequently, version two of the guidelines has recently been published in Australia, and New Zealand adapted these guidelines for formulation of their own national guidelines to accommodate local needs.
CONCLUSIONS
Here we describe the processes, acceptance and challenges associated with the establishment of these guidelines and measurement of their impact.
目的
2016 年，澳大利亚皇家病理学家学院（RCPA）成立了一个由医学微生物学家组成的工作组，制定指南以协助澳大利亚实验室实施抗生素的选择性和级联报告——这是世界上此类指南中的首例。
方法
2017 年对澳大利亚和新西兰实验室的抗生素报告进行的审计发现，选择性报告有很大的改进和标准化空间。
结果
2018 年 8 月，RCPA 选择性报告指南的第一份草案分发给所有 RCPA 微生物学研究员征求反馈意见，第一版于 2019 年 2 月发布。随后，该指南的第二版最近在澳大利亚发布，新西兰则根据这些指南制定了适合本国国情的国家指南，以满足当地的需求。
结论
在这里，我们描述了制定这些指南的过程、接受程度和挑战，并衡量了其影响。
Zotero 插件